Vasculitis & polymyalgia rheumatica

Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arteritis and IgA Vasculitis

Arthritis RheumatolPublished Genetic case-control association study

Main finding · Male patientsResult — go to the resultOdds ratio 1.23 95% CI 1.07–1.42

Authors' conclusion

This study reveals sex-dependent variation in C4 CN as a novel genetic risk factor for GCA and IgAV, suggesting shared biologic mechanisms involving complement dysregulation, sustained inflammation, and vascular damage.

Study context

Population
Patients with giant cell arteritis (GCA), patients with IgA vasculitis (IgAV), and controls with genotypic data
Participants
3,498 / 284 / 16,867
Comparison
Patients with GCA or IgAV vs controls
  • GCAn = 3,498
  • IgAVn = 284
  • Controlsn = 16,867reference
Outcome
Association of C4A, C4B and HERV-K copy number (CN) with vasculitis risk, overall and stratified by sex
Methodological detailscopy number imputation from genotypic data, sex-stratified analysis, conditional analyses on classical HLA alleles
  • Copy number imputation from genotypic data
  • Sex-stratified analysis
  • Conditional analyses on classical HLA alleles

Main finding

Male patients

Odds ratio

1.23

95% CI 1.07–1.42

P = 4.52 × 10-3

GCAvs Controls
OR 1.23 (95% CI 1.07–1.42); P = 4.52 × 10-3

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Elevated C4A CN and IgAV susceptibility, overall cohortIgAVvs ControlsPFDR = 4.48 × 10-31.68 (1.22–2.30)P = 1.49 × 10-3
C4B CN and IgAV, male-biased trendIgAVvs ControlsPFDR = 5.80 × 10-21.46 (1.02–2.08)P = 3.88 × 10-2

Independence from classical HLA alleles

Conditional analyses confirmed associations independent of classical HLA alleles

Original publication

Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arteritis and IgA Vasculitis. Arthritis Rheumatol. Published 27 April 2026. doi:10.1002/art.70203

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.